pet-adapted treatment in pmbcl
Published 3 years ago • 421 plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
3:42
early pet-adapted treatment for hodgkin lymphoma: 10-year follow-up analysis
-
3:05
the benefits of pet in the prognosis and treatment of hl
-
1:52
petrea: evaluating pet-adapted maintenance therapy approaches for patients with follicular lymphoma
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?
-
1:25
can a avd replace pet-directed strategies for the frontline treatment of hodgkin lymphoma?
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
2:35
association of interim pet2 response with outcomes in patients with dlbcl
-
5:57
treatment approaches, unmet needs, and ongoing research in younger patients with pmbcl
-
1:09
using bm and pet/ct to assess mrd status in myeloma & lymphoma patients post-car-t therapy
-
2:11
avenue window study: avelumab monotherapy followed by pet-adapted chemotherapy approach in chl
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
7:17
follicular lymphoma: br in the frontline and pre-treatment pet
-
1:22
pre-treatment pet scans
-
1:01
pitfalls in the diagnosis of lymphoid malignancies: interpreting pet scans
-
3:28
lymphoma: pre-treatment pet scans
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
6:02
predicting treatment outcomes in patients with r/r chl with ctdna and pet
-
1:13
utilizing pet/ct to improve staging in extranodal marginal zone lymphoma
-
1:51
checkpoint inhibition in the treatment of mpns